Management of risk factors for gastrointestinal bleeding in patients receiving anticoagulant therapy

Direct oral anticoagulants (DOACs) are used to prevent and treat thrombosis and thromboembolic events in patients with various diseases. Despite its high efficacy and safety, DOAC therapy is accompanied by increased risk of hemorrhage, including gastrointestinal bleeding. Bleeding risk depends on in...

Description complète

Détails bibliographiques

Auteurs principaux:	N. V. Bakulina, S. V. Tikhonov, N. B. Lishchuk, A. B. Karaya
Format:	Artigo
Langue:	Russo
Publié:	«FIRMA «SILICEA» LLC 2021-09-01
Collection:	Российский кардиологический журнал
Sujets:	anticoagulants direct oral anticoagulants rivaroxoban bleeding gastrointestinal bleeding proton pump inhibitors
Accès en ligne:	https://russjcardiol.elpub.ru/jour/article/view/4635
Tags:	Ajouter un tag Pas de tags, Soyez le premier à ajouter un tag!